A5056759500- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Biosimilars and Bioanalytical Methods
- Pharmaceutical industry and healthcare
- Antibiotic Use and Resistance
- Pharmaceutical studies and practices
- COVID-19 and healthcare impacts
- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Patient Satisfaction in Healthcare
- Global Cancer Incidence and Screening
- Primary Care and Health Outcomes
Karolinska Institutet
2021-2023
Introduction Prevalence rates for diabetes mellitus continue to rise, which, coupled with increasing costs of complications, has appreciably increased expenditure in recent years. Poor glycaemic control including hypoglycaemia enhances complication and associated morbidity, mortality costs. Consequently, this needs be addressed. Whilst the majority patients have type-2 diabetes, a considerable number require insulin help their diabetes. Long-acting analogues were developed reduce improve...
Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable universal healthcare access. Moreover, early market access of oncology lacking appropriate clinical evaluation generates uncertainty over cost-effectiveness and increases unknown health gain. Patient-level data can complement trials generate better evidence on the effectiveness, safety outcomes these in routine care. This support policy decisions including funding....
Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed reduce hypoglycaemia improve patient convenience. There are concerns though their considerably higher costs, but moderated reductions in costs. Biosimilars can help further However, date, price for biosimilar glargine appear limited. In addition,...